LONDON, June 28, 2022 /PRNewswire/ OME Health recently closed a new funding round led by Gen-tech Investments, with the participation of global pharmaceutical company Bayer AG, leading athletics company ASICS Ltd., and existing investors. The company also launched a B2B nutrition and health coaching platform to help health professionals manage and scale their practices. OME Health has used its recent collaborations with Manulife, ASICS, Bayer, and multiple high-profile research institutions to bring a number of innovations to the market. The platform enables health professionals to automate large parts of their workflow and access supplements and biological testing marketplaces. Practitioners can recommend tests to their clients and use the OME platform's algorithms to automatically interpret generated multi-omics and digital health data to deliver personalised nutrition and lifestyle recommendations, meal plans, and other engaging content via consumer apps. "I am very excit
LONDON, June 20, 2022 /PRNewswire/ OME Health recently closed a new funding round led by Gen-tech Investments, with the participation of global pharmaceutical company Bayer AG, leading athletics